Therefore, the aim of this study was to investigate the progression and survival after IILRR in human epidermal growth factor 2 (HER2)-negative luminal breast cancer and to identify prognostic factors affecting the progression and survival after IILRR in a large multi-center cohort. The gene discussed is ERBB2; the disease is breast carcinoma.